Literature DB >> 1254694

Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone.

S L Teitelbaum, E M Rosenberg, C A Richardson, L V Avioli.   

Abstract

Quantitative histological evaluations were made of nondecalcified iliac crest needle biopsies were obtained from 16 untreated, normocalcemic, normophosphatemic postmenopausal osteopenic females. Six of the patients had elevated circulating immunoreactive parathyroid hormone. Morphometric parameters, which were significantly increased in the hyperparathyroid group compared with the euparathyroid patients were the cortical osteoclast count and the percentage of trabecular surface covered by active or inactive osteoid. In addition, in all patients, the cortical osteoclast count, and the per cent of trabecular surface covered by osteoid and inactive osteoid were directly related to levels of immunoreactive parathyroid hormone. These data suggest that progressive osteopenia in some patients with crush fracture, or postmenopausal or senile osteoporosis, may be conditioned by an osteoclastosis, elevations in circulating parathyroid hormone, and a relative increase in poorly mineralized osteoid tissue. As such they emphasize the heterogeneity of a so-called "osteoporotic population" and stress the need for specific histological morphometric evaluation of bone before initiating long-term therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254694     DOI: 10.1210/jcem-42-3-537

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Effect of ovariectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows.

Authors:  K E Scholz-Ahrens; G Delling; P W Jungblut; E Kallweit; C A Barth
Journal:  Z Ernahrungswiss       Date:  1996-03

2.  The pathophysiology of bone and joint disease.

Authors:  S L Teitelbaum; P G Bullough
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

3.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Authors:  J C Gallagher; B L Riggs; J Eisman; A Hamstra; S B Arnaud; H F DeLuca
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

4.  Diagnosis and management of involutional osteoporosis.

Authors:  P M Hodsman
Journal:  Can Fam Physician       Date:  1979-04       Impact factor: 3.275

5.  Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women.

Authors:  M E Arlot; P D Delmas; D Chappard; P J Meunier
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

6.  Lack of hormonal changes in postmenopausal women of equal weight with and without osteoporosis, including relation to time of menopause.

Authors:  H Rico; A Charro; I Depablos; E Bordiu; E R Hernandez; D Espinos
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

7.  Evaluation of diffusely high uptake by the calvaria in bone scintigraphy.

Authors:  K Senda; S Itoh
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

8.  Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.

Authors:  D M Slovik; R M Neer; J T Potts
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.

Authors:  R Civitelli; D Agnusdei; P Nardi; F Zacchei; L V Avioli; C Gennari
Journal:  Calcif Tissue Int       Date:  1988-02       Impact factor: 4.333

10.  Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.

Authors:  W D Fraser; F C Logue; J P Christie; S J Gallacher; D Cameron; D S O'Reilly; G H Beastall; I T Boyle
Journal:  Osteoporos Int       Date:  1998       Impact factor: 5.071

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.